Impact of the interaction between herpes simplex virus 1 ICP22 and FACT on viral gene expression and pathogenesis
Journal of Virology · 2024
DOI: 10.1128/jvi.00737-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Shaocong Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Nucleosomes, Transcription, Genetic, Gene Expression Regulation, Viral, Herpesvirus 1, Human. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), Ministry of Education, Culture, Sports, Science and Technology (MEXT), MEXT | Japan Science and Technology Agency (JST).
Abstract (Originalsprache)
Facilitates chromatin transcription (FACT) interacts with nucleosomes to promote gene transcription by regulating the dissociation and reassembly of nucleosomes downstream and upstream of RNA polymerase II (Pol II). A previous study reported that herpes simplex virus 1 (HSV-1) regulatory protein ICP22 interacted with FACT and was required for its recruitment to the viral DNA genome in HSV-1-infected cells. However, the biological importance of interactions between ICP22 and FACT in relation to HSV-1 infection is unclear. Here, we mapped the minimal domain of ICP22 required for its efficient interaction with FACT to a cluster of five basic amino acids in ICP22. A recombinant virus harboring alanine substitutions in this identified cluster led to the decreased accumulation of viral mRNAs from UL54, UL38, and UL44 genes, reduced Pol II occupancy of these genes in MRC-5 cells, and impaired HSV-1 virulence in mice following ocular or intracranial infection. Furthermore, the treatment of mice infected with wild-type HSV-1 with CBL0137, a FACT inhibitor currently being investigated in clinical trials, significantly improved the survival rate of mice. These results suggested that the interaction between ICP22 and FACT was required for efficient HSV-1 gene expression and pathogenicity. Therefore, FACT might be a potential therapeutic target for HSV-1 infection. IMPORTANCE ICP22 is a well-known regulatory factor of HSV-1 gene expression, but its mechanism(s) are poorly understood. Although the interaction of FACT with ICP22 was reported previously, its significance in HSV-1 infection is unknown. Given that FACT is involved in gene transcription, it is of interest to investigate this interaction as it relates to HSV-1 gene expression. To determine a direct link between the interaction and HSV-1 infection, we mapped a minimal domain of ICP22 required for its efficient interaction with FACT and generated a recombinant virus carrying mutations in the identified domain. Using the recombinant virus, we obtained evidence suggesting that the interaction between ICP22 and FACT promoted Pol II transcription from HSV-1 genes and viral virulence in mice. In addition, CBL0137, an inhibitor of FACT, effectively protected mice from lethal HSV-1 infection, suggesting FACT might be a potential target for the development of novel anti-HSV drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- Pandemic Preparedness, Infection and Advanced Research Center, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Yuhei Maruzuru, Yasushi Kawaguchi
Förderung
- MEXT | Japan Society for the Promotion of Science (JSPS)
- Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- MEXT | Japan Science and Technology Agency (JST)
- Japan Agency for Medical Research and Development (AMED)
Zitieren
APA
Liu, S., Maruzuru, Y., Takeshima, K., Koyanagi, N., Kato, A., & Kawaguchi, Y. (2024). Impact of the interaction between herpes simplex virus 1 ICP22 and FACT on viral gene expression and pathogenesis. Journal of Virology. https://doi.org/10.1128/jvi.00737-24
Vancouver
Liu S, Maruzuru Y, Takeshima K, Koyanagi N, Kato A, Kawaguchi Y. Impact of the interaction between herpes simplex virus 1 ICP22 and FACT on viral gene expression and pathogenesis. Journal of Virology. 2024. doi:10.1128/jvi.00737-24
BibTeX
@article{Liu2024,
author = {Liu, Shaocong and Maruzuru, Yuhei and Takeshima, Kosuke and Koyanagi, Naoto and Kato, Akihisa and Kawaguchi, Yasushi},
title = {Impact of the interaction between herpes simplex virus 1 ICP22 and FACT on viral gene expression and pathogenesis},
journal = {Journal of Virology},
year = {2024},
doi = {10.1128/jvi.00737-24}
}
EUVIMED